Significant Ownership of FEDERATED HERMES, INC.
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for FEDERATED HERMES, INC. focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- /s/J. Christopher Donahue - J. Christopher Donahue, as President of Federated Hermes, Inc.
- Manager location
- Pittsburgh, PA
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow FEDERATED HERMES, INC. with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from FEDERATED HERMES, INC.
Significant Ownership of FEDERATED HERMES, INC.
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NERV | Minerva Neurosciences, Inc. | COMMON STOCK | 17% | $40,152,078 | -$3,240,232 | 8,690,926 | -7.5% | Federated Hermes, Inc. | 30 Jun 2026 |
| ARCT | Arcturus Therapeutics Holdings Inc. | COMMON STOCK | 12% | $20,250,983 | 3,303,640 | Federated Hermes, Inc. | 31 Dec 2025 | ||
| FBRX | Forte Biosciences, Inc. | COMMON STOCK | 10% | $34,865,724 | +$7,849,247 | 2,110,516 | +29% | Federated Hermes, Inc. | 30 Jun 2026 |
| ATYR | aTYR PHARMA INC | COMMON STOCK | 8.7% | $5,075,172 | -$1,213,530 | 8,509,678 | -19% | Federated Hermes, Inc. | 30 Jun 2026 |
| EYPT | EYEPOINT PHARMACEUTICALS, INC. | COMMON STOCK | 6.7% | $43,281,744 | 4,599,450 | Federated Hermes, Inc. | 30 Jun 2025 | ||
| LFMD | LifeMD, Inc. | COMMON STOCK | 5.7% | $11,346,716 | 2,747,655 | Federated Hermes, Inc. | 30 Jun 2026 | ||
| TTEC | TTEC HOLDINGS, INC. | COMMON STOCK | 5.2% | $9,862,428 | 2,541,863 | Federated Hermes, Inc. | 31 Dec 2025 | ||
| AAP | ADVANCE AUTO PARTS INC | COMMON STOCK | 5.1% | $160,502,161 | 3,042,695 | Federated Hermes, Inc. | 31 Mar 2026 | ||
| MGPI | MGP INGREDIENTS, INC. | COMMON STOCK | 4.6% | $17,171,408 | -$3,743,506 | 980,092 | -18% | Federated Hermes, Inc. | 30 Jun 2026 |
| OVID | Ovid Therapeutics Inc. | COMMON STOCK | 4.2% | $17,099,137 | 7,737,166 | 0% | Federated Hermes, Inc. | 30 Jun 2026 | |
| SCYX | SCYNEXIS INC | COMMON STOCK | 4% | $309,161 | -$2,164,114 | 441,658 | -87% | Federated Hermes, Inc. | 30 Jun 2026 |
| IDYA | IDEAYA Biosciences, Inc. | COMMON STOCK | 3.9% | $117,393,162 | 3,395,771 | Federated Hermes, Inc. | 31 Dec 2025 | ||
| SSTI | SOUNDTHINKING, INC. | COMMON STOCK | 3.5% | $2,979,000 | -$3,641,000 | 450,000 | -55% | Federated Hermes, Inc. | 31 Mar 2026 |
| SPCE | VIRGIN GALACTIC HOLDINGS, INC. | COMMON STOCK | 0.51% | $650,954 | -$5,413,263 | 209,985 | -89% | Federated Hermes, Inc. | 31 May 2025 |
Schedules 13D/G Reported by FEDERATED HERMES, INC.:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.